These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
552 related items for PubMed ID: 32081240
21. Efficacy and safety of renal denervation in elderly patients with resistant hypertension. Ziegler AK, Bertog S, Kaltenbach B, Id D, Franke J, Hofmann I, Vaskelyte L, Sievert H. Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010 [Abstract] [Full Text] [Related]
22. First-in-Man Experience with a Novel Catheter-Based Renal Denervation System of Ultrasonic Ablation in Patients with Resistant Hypertension. Chernin G, Szwarcfiter I, Scheinert D, Blessing E, Diehm N, Dens J, Walton A, Verheye S, Shetty S, Jonas M. J Vasc Interv Radiol; 2018 Aug; 29(8):1158-1166. PubMed ID: 29921526 [Abstract] [Full Text] [Related]
23. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial. Fengler K, Heinemann D, Okon T, Röhnert K, Stiermaier T, von Röder M, Besler C, Müller U, Höllriegel R, Schuler G, Desch S, Lurz P. Clin Res Cardiol; 2016 Jul; 105(7):592-600. PubMed ID: 26728060 [Abstract] [Full Text] [Related]
34. Renal Denervation in the Management of Hypertension: A Meta-Analysis of Sham-Controlled Trials. Dahal K, Khan M, Siddiqui N, Mina G, Katikaneni P, Modi K, Azrin M, Lee J. Cardiovasc Revasc Med; 2020 Apr 26; 21(4):532-537. PubMed ID: 31420197 [Abstract] [Full Text] [Related]
35. Ultra-long-term efficacy and safety of catheter-based renal denervation in resistant hypertension: 10-year follow-up outcomes. Al Ghorani H, Kulenthiran S, Lauder L, Recktenwald MJM, Dederer J, Kunz M, Götzinger F, Ewen S, Ukena C, Böhm M, Mahfoud F. Clin Res Cardiol; 2024 Oct 26; 113(10):1384-1392. PubMed ID: 38451261 [Abstract] [Full Text] [Related]
36. Randomized Trials of Renal Denervation for Uncontrolled Hypertension: An Updated Meta-Analysis. Mufarrih SH, Qureshi NQ, Khan MS, Kazimuddin M, Secemsky E, Bloch MJ, Giri J, Cohen D, Swaminathan RV, Feldman DN, Alaswad K, Kirtane A, Kandzari D, Aronow HD. J Am Heart Assoc; 2024 Aug 20; 13(16):e034910. PubMed ID: 39140334 [Abstract] [Full Text] [Related]
37. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Lancet; 2009 Apr 11; 373(9671):1275-81. PubMed ID: 19332353 [Abstract] [Full Text] [Related]
38. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Symplicity HTN-2 InvestigatorsBaker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road, Central Melbourne, VIC 8008, Australia. murray.esler@bakeridi.edu.au, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Lancet; 2010 Dec 04; 376(9756):1903-9. PubMed ID: 21093036 [Abstract] [Full Text] [Related]